# MinV

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/minv

- Industry: Software
- Headquarters: Guangzhou, China
- Website: www.vdaifu.com
- Latest round: Series C (Nov 1, 2019)
- Investors on record: 4

## About

Established in 2014 and based in Guangzhou, China, MinV operates a medical cloud platform that focuses on providing cloud-based medical solutions. The company is headquartered in Guangzhou, with 9 branches in Guangzhou, Changsha, Jinan and Beijing, and Vdaifu HK Limited in Hong Kong. It has a team of 55 employees, and its founder and CEO, Wang Yinhui, graduated with an engineering master's degree from South China University of Technology in 2007. From 2019-2023, the company was selected as one of Guangzhou's "Future Unicorn" high-tech enterprises for five consecutive years, and has been awarded the honorary title of "Specialized, Specialized and New" enterprise in Guangdong Province in 2022 and 2023.

The company offers a suite of cloud computing SaaS services aimed at enhancing digital management and smart healthcare for grassroots medical institutions and public health systems. Their core products include "Cloud Clinic," designed to improve patient care and service efficiency, and "Cloud Public Health," which leverages technologies like cloud computing, 5G, and NB-IoT for public health digital services. Additionally, they provide integrated solutions that link the healthcare industry's upstream and downstream, offering end-to-end services.

The company generates revenue by offering cloud-based software solutions and services that cater to the healthcare industry's needs for digitization and intelligent management.

## Funding rounds

- Series C, Nov 1, 2019 — Yunqi Partners, MPC, Jiyuan Capital
- Series B, Oct 1, 2016 — SIG Asia Investment, MPC

## Investors

- SIG Asia Investment (https://capitalatlas.ai/funds/sig-asia-investment) — Series B
- MPC — Series B, Series C
- Yunqi Partners (https://capitalatlas.ai/funds/yunqi-partners) — Series C
- Jiyuan Capital (https://capitalatlas.ai/funds/jiyuan-capital) — Series C